Aptar Pharma, a provider of drug delivery systems, has acquired all device technology assets from SipNose Nasal Delivery Systems’ portfolio, expanding its presence in the intranasal drug ...

CRYSTAL LAKE, Ill., October 09, 2024--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announces that it has acquired ...

The Board of Directors of AptarGroup, Inc. (NYSE: ATR) authorized the repurchase of up to $500 million of the Company’s common stock. This new authorization replaces all previous authorizations.

AptarGroup, Inc. (NYSE:ATR – Get Free Report)’s stock price reached a new 52-week high during trading on Friday following a dividend announcement from the company. The company traded as high as ...

CRYSTAL LAKE, Ill. - AptarGroup, Inc. (NYSE: NYSE:ATR), a global provider of a wide range of dispensing, sealing and material science solutions for various industries, has announced a new share ...

The U.S. Food & Drug Administration has accepted Crystal Lake, Ill.-based Aptar Pharma's N-Sorb nitrosamine mitigation solution into its Emerging Technology Program, which works with companies on ...

On Monday, Baird reaffirmed its positive stance on AptarGroup (NYSE:ATR) shares, a company traded on the New York Stock Exchange under the ticker NYSE:ATR, maintaining both an Outperform rating ...

CRYSTAL LAKE, Ill. - AptarGroup, Inc. (NYSE: NYSE:ATR), a global provider of a wide range of dispensing, sealing and material science solutions for various industries, has announced a new share ...

DBS analyst Nico Chen maintained a Hold rating on AptarGroup (ATR – Research Report) today and set a price target of $141.70. Nico Chen has given his Hold rating due to a combination of factors ...

On Monday, Baird reaffirmed its positive stance on AptarGroup (NYSE:ATR) shares, a company traded on the New York Stock Exchange under the ticker NYSE:ATR, maintaining both an Outperform rating and a ...

The U.S. Food & Drug Administration has accepted Crystal Lake-based Aptar's N-Sorb nitrosamine mitigation solution into its Emerging Technology Program. The program works with companies on new ...